Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Connexin43 in mesenchymal lineage cells regulates body adiposity and energy metabolism in mice
Seung-Yon Lee, … , Ariella Coler-Reilly, Roberto Civitelli
Seung-Yon Lee, … , Ariella Coler-Reilly, Roberto Civitelli
Published February 13, 2024
Citation Information: JCI Insight. 2024;9(6):e170016. https://doi.org/10.1172/jci.insight.170016.
View: Text | PDF
Research Article Metabolism

Connexin43 in mesenchymal lineage cells regulates body adiposity and energy metabolism in mice

  • Text
  • PDF
Abstract

Connexin43 (Cx43) is the most abundant gap junction protein present in the mesenchymal lineage. In mature adipocytes, Cx43 mediates white adipose tissue (WAT) beiging in response to cold exposure and maintains the mitochondrial integrity of brown adipose tissue (BAT). We found that genetic deletion of Gja1 (Cx43 gene) in cells that give rise to chondro-osteogenic and adipogenic precursors driven by the Dermo1/Twist2 promoter led to lower body adiposity and partial protection against the weight gain and metabolic syndrome induced by a high-fat diet (HFD) in both sexes. These protective effects were related to increased locomotion, fuel utilization, energy expenditure, nonshivering thermogenesis, and better glucose tolerance in conditionally Gja1-ablated mice. Accordingly, Gja1-mutant mice exhibited reduced adipocyte hypertrophy, partially preserved insulin sensitivity, increased BAT lipolysis, and decreased whitening under HFD. This metabolic phenotype was not reproduced with more restricted Gja1 ablation in differentiated adipocytes, suggesting that Cx43 in adipocyte progenitors or other targeted cells restrains energy expenditures and promotes fat accumulation. These results reveal what we believe is a hitherto unknown action of Cx43 in adiposity, and offer a promising new pharmacologic target for improving metabolic balance in diabetes and obesity.

Authors

Seung-Yon Lee, Francesca Fontana, Toshifumi Sugatani, Ignacio Portales Castillo, Giulia Leanza, Ariella Coler-Reilly, Roberto Civitelli

×

Figure 6

Gja1 ablation in mesenchymal lineage cells increases locomotor activity, food consumption, and energy expenditure.

Options: View larger image (or click on image) Download as PowerPoint

Gja1 ablation in mesenchymal lineage cells increases locomotor activity...
Five-month-old cKOTW2 (red, n = 6) and WT (blue; n = 8) male mice were placed in metabolic cages after being fed an HFD for 12 weeks, and continuously monitored for 48 hours. (A and B) Food consumption, (C and D) energy expenditures, (E and F) respiratory exchange rate (VCO2/O2), and (G and H) locomotor activity. Data are presented as hourly averages (A, C, E, and G) and were analyzed using general linear models or ANOVA (detailed results in Supplemental Table 2; P values are given for genotype effect), and daily averages over the 2-day experiment for each time period (B, D, F, and H), with groups compared using 1-way ANOVA.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts